Pharma Marketing Network
MAY 15, 2025
In a world of podcasts , reels, and AI-written content, its fair to ask: are white papers still pulling their weight in pharma marketing? For teams navigating omnichannel campaigns, strict MLR approvals, and buyer fatigue, the answer isn’t just “yes”it’s if done right, they work better than ever. Once the domain of technical audiences and B2B legacy brands, white papers have evolved.
STAT
MAY 13, 2025
Leading trade organizations representing the makers of cell and gene therapies are calling for a 10-year international moratorium on the use of CRISPR and other DNA-editing tools to create genetically modified children, according to a draft of the declaration provided to STAT. The move — coming more than seven years after Chinese researcher He Jiankui announced the birth of the world’s first CRISPR babies — is intended to send a clear signal to the global scientific co
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
PharmaVoice
MAY 15, 2025
Amy Parison, who stepped into the lead financial role at the company in March, is managing Editas Medicine’s transition to a new gene editing platform while recovering from a major overhaul.
BioPharma Dive
MAY 15, 2025
Shares of the biotech fell around 15% on news the FDA is not only taking longer to review the drug, but will assemble an outside group of advisers to evaluate it as well.
Speaker: Jennifer Hill
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Express Pharma
MAY 11, 2025
Accretion Pharmaceuticals, an Ahmedabad-headquartered pharmaceuticals manufacturer, announced that its initial public offering (IPO) will open for subscription on Wednesday, May 14, 2025. The anchor portion will be opened on Tuesday, May 13, 2025, and the issue will conclude on Friday, May 16, 2025. The company intends to raise 29.75 crore from the offering and aims to be listed on the NSE Emerge platform.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Pharma Times
MAY 15, 2025
Aspire-FTD study aims to stop disease progression with one-time treatment
BioPharma Dive
MAY 15, 2025
A gene editing drug custom-made for a critically ill baby showed that, for some ultra-rare diseases, it’s possible to design and test a new CRISPR medicine in just a few months.
Drug Patent Watch
MAY 15, 2025
"Unlocking the Secrets of the FDA's Orange and Purple Books: Insider Tips from a Drug Patent Research Expert As the pharmaceutical industry continues to evolve at breakneck speed, staying ahead of the curve requires more than just a keen eye for innovation it demands a deep understanding of the regulatory landscape. For those in the know, the FDA's Orange and Purple Books hold the key to unlocking the secrets of the industry's most closely guarded information.
STAT
MAY 13, 2025
For a recent therapy session, Andria Donaghy’s insurance plan paid her psychiatric nurse practitioner only $11 on a $125 service. “To even put that on paper is insulting,” she said. “These people give their lives [to help others] and that’s what you pay them?
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
EMCrit Project
MAY 15, 2025
Our first episode uses a simple case to act as touch-point for a discussion of resus nursing in the ED. EMCrit Project by Scott Weingart, MD FCCM.
pharmaphorum
MAY 14, 2025
Andrew Witty has resigned as CEO of US health conglomerate UnitedHealth, as the company pulled its financial forecasts for 2025
The Pharmacist
MAY 15, 2025
Delivering nationally-commissioned NHS pharmacy services could generate enough income to pay the wages of an additional staff member, Community Pharmacy North East London chief executive has suggested. Delivering just 20 NHS consultations each week could generate as much as 451.70, Shilpa Shah told contractors this week at the Sigma 2025 conference in Baku, Azerbaijan.
STAT
MAY 15, 2025
SAN FRANCISCO — Lurking beneath the shiny promise of artificial intelligence in health care is a host of potential liability issues. Chief among them: a lack of consent from patients, whether any doctor checks the machine’s work, and, if they do, whether that even helps. A panel of legal and medical experts at STAT’s Breakthrough Summit West explained the myriad legal questions hanging over the adoption of AI in health care.
Advertisement
Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.
Drug Patent Watch
MAY 13, 2025
"Millions Lost in the Shadows: Uncovering the Hidden Costs of Ineffective Procurement Strategies in the Pharmaceutical Industry As the pharmaceutical industry grapples with rising costs and shrinking profit margins, a stealthy culprit is quietly draining resources: procurement mistakes. A new report reveals that inadequate procurement practices are costing pharma businesses millions, threatening the very foundation of their operations.
Pharmaceutical Technology
MAY 15, 2025
The FDA has approved MSDs Welireg for rare adrenal tumours, and AbbVies Emrelis for treating c-Met+ lung cancer patients.
pharmaphorum
MAY 15, 2025
AbbVie has claimed its first global regulatory approval, from the FDA, for its C-met-targeting lung cancer ADC Emrelis
STAT
MAY 14, 2025
WASHINGTON — In hours of combative congressional hearings Wednesday, health secretary Robert F. Kennedy Jr. swung between defending sweeping changes at his agency and backtracking on aspects of a reorganization he nevertheless said would be “painful.” He repeatedly cast doubts on reports about negative impacts of the changes, often calling them a “canard.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Express Pharma
MAY 15, 2025
STEERLife, the life sciences division of STEER World, is advancing the development and manufacturing of potent and complex drug products. At the core of this advancement is STEERLife’s solvent-free melt fusion technology, a continuous processing system that eliminates the need for harmful organic solvents. Designed to handle high-potency and hard-to-develop molecules, this platform significantly enhances formulation efficiency, safety, and scalability.
Pharmafile
MAY 13, 2025
Newron Pharmaceuticals has announced the approval for its ENIGMA-TRS phase 3 development programme evaluating evenamide as an add-on therapy to current antipsychotics in patients with treatment-resistant schizophrenia (TRS). This is a significant milestone Newrons endeavour to rollout the therapy as a conventional treatment for these patients. The ENIGMA-TRS phase 3 development programme consists of two […] The post Newrons programme for treatment-resistant schizophrenia therapy approved a
pharmaphorum
MAY 15, 2025
Sanofi is the latest European pharma group to promise a big capital investment programme on manufacturing and R&D in the US
STAT
MAY 12, 2025
The now 13-year-long legal saga over who invented CRISPR took yet another unexpected turn on Monday, in a ruling that could not only change U.S. ownership of patent rights to the groundbreaking gene-editing technology but more broadly redefine how the law determines when an invention has been made. The U.S. Court of Appeals for the Federal Circuit sided with the University of California and the University of Vienna in their bid to revive a fight over foundational CRISPR-Cas9 patents that t
Speaker: Joe Sharpe and James Carlson
Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.
BioPharma Dive
MAY 15, 2025
ADARx Pharmaceuticals will work with AbbVie to make RNA interference medicines for a variety of disease areas, including neurology, immunology and cancer.
Pharma Marketing Network
MAY 12, 2025
Ever tried shouting in a crowded stadium? Thats what it feels like launching a branded healthcare campaign today. With every pharma brand, health system, and startup clamoring for attention, crafting a successful healthcare marketing strategy has never been more challengingor more necessary. In 2025, reaching healthcare professionals (HCPs), patients, and caregivers requires more than budget and brand equity.
Express Pharma
MAY 15, 2025
Lupin announced that it has received approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application for Rivaroxaban Tablets USP, 10 mg, 15 mg, and 20 mg. Rivaroxaban Tablets are bioequivalent to Xarelto Tablets, 10 mg, 15 mg, and 20 mg, of Janssen Pharmaceuticals. This product will be manufactured at Lupins Aurangabad facility in India.
STAT
MAY 15, 2025
WASHINGTON — Food and Drug Administration Commissioner Marty Makary said the agency is planning to unveil new guidance for vaccine makers, focused primarily on Covid-19 shots, in the coming weeks. “We want to be very transparent, and we want to create a framework for vaccine makers that they can use so they have a predictable FDA where they don’t have to worry,” Makary said at the Food and Drug Law Institute conference on Thursday.
Advertisement
Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.
Pharmaceutical Commerce
MAY 15, 2025
A qualitative study aimed to strengthen systematic repurposing efforts within rare disease nonprofit organizations, while also providing a framework for data-driven drug repurposing.
Pharmafile
MAY 15, 2025
Kaerus Bioscience announces that its lead candidate KER-0193 has been granted both Orphan Drug Designation (ODD) and Rare Pediatric Drug Designations (RPDD) for the treatment of Fragile X syndrome (FXS) by the US Food and Drugs Administration (FDA). Created by Medicxi, the global biopharma is focused on the development of therapeutics for rare genetic syndromes […] The post Kaerus Bioscience secures FDA approval for rare genetic disorder treatment appeared first on Pharmafile.
The Thyroid Pharmacist
MAY 15, 2025
If youre a woman, its likely that youve experienced a urinary tract infection (UTI) at some point in your life. Some of us might even experience them more frequently than wed like (if thats you keep reading!). Between 50 and 60 percent of women will experience at least one UTI in their lifetime, and the prevalence of UTIs increases as we age. [1] In fact, its the most common outpatient infection in the U.S.
Expert insights. Personalized for you.
52 
Let's personalize your content